GSK PLC 4Q Pre-items, Pretax Pft GBP8.11B
Corrections & Amplifications This headline was corrected at 0731 GMT to reflect GSK PLC 4Q Pre-Items, Pre-Tax Pft GBP1.56B, not GBP8.11B Corrections &...
Stay updated with breaking news from Visible Alpha. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Corrections & Amplifications This headline was corrected at 0731 GMT to reflect GSK PLC 4Q Pre-Items, Pre-Tax Pft GBP1.56B, not GBP8.11B Corrections &...
By Joe Hoppe GSK said its sales rose, driven by growth in its best-selling shingles vaccine Shingrix and the launch of RSV vaccine Arexvy earlier last year, and raised its guidance for 2024....
By Joe Hoppe GSK expects to further grow sales and earnings after its best-selling shingles vaccine Shingrix and the launch of RSV vaccine Arexvy helped the...
By Adria Calatayud Novartis is scheduled to report results for the fourth quarter on Wednesday. Here is what you need to know. SALES FORECAST: The Swiss...
By Joe Hoppe GSK is scheduled to report results for 2023 and the fourth quarter on Wednesday. Here is what you need to know: SALES FORECAST: Full-year sales...